셀메드 (CELLMED)

  • 제14권2호
  • /
  • Pages.5.1-5.4
  • /
  • 2024
  • /
  • 3022-6805(pISSN)
  • /
  • 3022-6791(eISSN)
셀메드 세포교정의약학회 (Cellmed Orthocellular Medicine and Pharmaceutical Association)
권호 표지
DOI QR코드

DOI QR Code

Effect of unani formulation in PCOS: A case report

  • Afifa Naaz (National institute of unani medicine)
  • 투고 : 2024.01.31
  • 심사 : 2024.02.29
  • 발행 : 2024.02.29
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

PCOS is the most common endocrine pathology in females of reproductive worldwide. The prevalence ranges between 5% and 15% depending on the diagnostic criteria applied.Its etiology involves both genetic and environmental factors. Typically, women with PCOS show clinical and biochemical hyperandrogenism, oligoanovulation, and micropolycystic morphology of the ovaries. Unani formulation containing Nankhwah, Badiyan and Wajturki possessing the properties of Mudirr-i-Bawl-o- Hayd, mujaff -iBalgham, Munaffis-i- balgham, Muhallil, Muqawwi-i-Jigar were used in the form of Joshanda 6gm BD Starting from 5 days prior to expected period date to 5 days during menses for 3 cycles, which led to regain regularity of menses, correcting the amount of flow and reducing the ovarian volume on US. Thus unani medications have the potential to treat ths symtoms of PCOS and improve the quality of life of women.

키워드

과제정보

National Institute of Unani Medicine And Dept of Ilmul Qabalat Wa Amraz Niswan

참고문헌

  1. Sadeghi, H. M. et al. Polycystic ovary syndrome: a comprehensive review of pathogenesis, management, and drug repurposing. 23, 583 (2022).
  2. MUHAS, C. et al. POLYCYSTIC OVARY SYNDROME (PCOS)-AN OVERVIEW. 10, 5-9 (2018).
  3. Yasmin, A. et al. Polycystic ovary syndrome: An updated overview foregrounding impacts of ethnicities and geographic variations. 12, 1974 (2022). https://doi.org/10.3390/life12121974
  4. Witchel, S. F., Oberfield, S. E. & Pena, A. S. J. J. o. t. E. S. Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls. 3, 1545-1573 (2019). https://doi.org/10.1210/js.2019-00078
  5. Louwers, Y. V. & Laven, J. S. J. T. A. i. R. H. Characteristics of polycystic ovary syndrome throughout life. 14, 2633494120911038 (2020).
  6. Zeng, L.-H. et al. Polycystic ovary syndrome: a disorder of reproductive age, its pathogenesis, and a discussion on the emerging role of herbal remedies. 13, 874914 (2022).
  7. Escobar-Morreale, H. F. J. N. R. E. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. 14, 270-284 (2018).
  8. Bulsara, J., Patel, P., Soni, A., Acharya, S. J. E. & Science, M. A review: Brief insight into Polycystic Ovarian syndrome. 3, 100085 (2021). https://doi.org/10.1016/j.endmts.2021.100085
  9. Bashir, A., Guha, L. & Bhat, I. A. J. J. G. W. H. Comprehension, management, and treatment of polycystic ovarian syndrome via allopathic, Unani and ayurvedic perspectives. 21, 1-9 (2021).
  10. Firdose, K. F. & Shameem, I. J. I. j. a. r. An approach to the management of poly cystic ovarian disease in Unani system of medicine: A review. 2, 585-590 (2016).
  11. Syed, A. F. & Ahmed, J. J. I. J. o. A. i. H. S. Marz Akyas Khusyatur Rehm (Polycystic Ovary Syndrome): An Overview. 3, 119-128 (2016).
  12. Sheeraz, M. Concept and management of Polycystic Ovarian Syndrome In Greco Arabian Medicine: A Review Study. World Journal of Pharmaceutical Research. 7, 487-501. (2020).
  13. Hakeem, H. M. A. Bustanul Mufradath. New Delhi 56 (2002).
  14. H., K. Makhzanul Mufradath (2007).
  15. Naquvi, K. J. et al. A review on phytochemical investigations and biological activities of Trachyspermum ammi (L.) sprague. 15, 2364-2370 (2022). https://doi.org/10.52711/0974-360X.2022.00393
  16. Debnath, S., Kumar, H., Sharma, A. J. T. & Medicine, I. Foeniculum vulgare from Spice to Pharma: Recent Advances in Its Medicinal Value, Bioactivities and Perspectives. 217-229 (2023).
  17. kharat SR, S. P., Pathan R. An overview on Vacha (Acorus calamus L.) with special reference to Ayurvedic and modern aspect. International Journal of Pharmaceutical Research and Applications. Apr;8(2):594-601 (2023 ).